Navigation Links
Spheris Reports Third Quarter 2008 Results
Date:11/12/2008

FRANKLIN, Tenn., Nov. 12 /PRNewswire/ -- Spheris, a leading global provider of clinical documentation technology and services, today announced results for the three and nine month periods ended September 30, 2008.

Financial Highlights--Third quarter of 2008

Net revenues for the third quarter of 2008 were $44.7 million compared with $48.9 million in the third quarter of 2007. The decrease in net revenues was due primarily to the impact of net lost business and lower average pricing.

Operating income for the third quarter of 2008 was $1.2 million, or 2.7% of net revenues, compared with operating income of $1.5 million, or 3.1% of net revenues, in the third quarter of 2007. The decrease in operating income was due to lower net revenues, accelerated technology investments to further develop and enhance our product and service offerings, as well as costs associated with the expansion of our global capacity. These costs were partially offset by operational cost savings from increased utilization of our global production workforce and speech recognition technologies, in addition to other cost savings initiatives.

The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, and other expense or income. Adjusted EBITDA for the third quarter of 2008 was $7.0 million, or 15.7% of net revenues, compared with $7.6 million, or 15.5% of net revenues, in the third quarter of 2007. The decrease in Adjusted EBITDA was due primarily to the impact of lower net revenues and the accelerated technology investments described above.

Adjusted EBITDA is a financial measure not computed in accordance with United States generally accepted accounting principles, or GAAP. Please refer to the "Supplemental Financial Information" and related note contained in this press release for further discussion and reconciliation of Adjusted EBITDA to GAAP financial measures.

Financial Highlights--First Nine months of 2008

Net revenues for the nine month period ended September 30, 2008 were $141.1 million compared with $151.8 million in the prior-year period. The decrease in net revenues was due primarily to the impact of net lost business and lower average pricing.

Operating income for the nine month period ended September 30, 2008 was $1.0 million, or 0.7% of net revenues, compared with operating income of $6.1 million, or 4.0% of net revenues, in the prior-year period. During the first quarter of 2008, the Company recorded $1.3 million of expenses relating to a transaction that was not consummated. Excluding these transaction costs, operating income would have been $2.3 million, or 1.6% of net revenues, for the nine month period ended September 30, 2008. In addition to the impact of the transaction costs, the decrease in operating income was due primarily to lower net revenues as described above, accelerated technology investments to further develop and enhance our product and service offerings, as well as costs associated with the expansion of our global capacity. These costs were partially offset by operational cost savings from increased utilization of our global production workforce and speech recognition technologies, in addition to other cost savings initiatives.

Adjusted EBITDA for the nine month period ended September 30, 2008 was $18.7 million, or 13.3% of net revenues, compared with $24.3 million, or 16.0% of net revenues, in the prior-year period. Excluding the $1.3 million of transaction related expenses noted above, Adjusted EBITDA would have been $20.0 million, or 14.2% of net revenues, for the nine month period ended September 30, 2008. The decrease in Adjusted EBITDA was primarily due to the impact of lower net revenues, accelerated technology investments, and transaction costs described above.

Commenting on the third quarter 2008 results, Steven E. Simpson, President and Chief Executive Officer of Spheris, stated, "The third quarter and year-to-date results reflect the challenges in today's marketplace, but we remain encouraged by opportunities we are seeing. As our technology developments progress, we continue to accelerate the efficiencies gained from both our speech recognition tools and global resources. We have received positive feedback as a result of successfully demonstrating the new features and functionality through an intensive pilot program that led to signing a significant new account."

Simpson added, "Even though we are pleased with the products coming out of development, our goal remains to be the first to market with an end-to-end clinical documentation technology and service offering."

Balance Sheet Highlights

As of September 30, 2008, the outstanding indebtedness under the Company's senior secured credit facility was $77.3 million and the outstanding indebtedness under the Company's senior subordinated notes was $125.0 million.

Liquidity Highlights

As of September 30, 2008, Spheris held $9.9 million in unrestricted cash and cash equivalents and had $17.7 million of borrowing capacity under the Company's senior secured credit facility. During the first nine months of 2008, the Company generated $1.0 million of cash from operating activities compared with $9.8 million during the same period in 2007. The decrease in cash generated from operating activities was attributable to the year over year change in operating performance, timing of wages and benefit payments, and the current period payment of certain security deposits, as offset by the favorable impact of improved collections on accounts receivable.

Investor Conference Call and Webcast

Spheris will host a conference call on November 13, 2008, at 8 a.m. CT. The number to call for this interactive teleconference is (303) 262-2130. Following the conference call, the audio replay will be available for one week by dialing (303) 590-3000 and entering the confirmation number, 11111017#. The live broadcast of Spheris' quarterly conference call will be available online at http://www.spheris.com and http://www.videonewswire.com/event.asp?id=52756 on November 13, 2008, at 8 a.m. CT. The online replay will be available shortly after the call and will continue to be available for 30 days.

About Spheris

Spheris is a leading global provider of clinical documentation technology and services to more than 500 health systems, hospitals and group practices throughout the U.S. Spheris offers a highly advanced, Web-based technology platform blended with Spheris' outsource services. Spheris employs approximately 5,000 skilled medical language specialists supporting the Company's clients through a secure network. Using a Follow the Sun(sm) service strategy, customer support is provided 24 hours a day, 365 days a year with an emphasis on verifiable quality, turnaround time and pricing. Spheris' corporate headquarters is located in Franklin, Tenn. For more information, please visit http://www.spheris.com .

Forward-Looking Statements

This press release contains statements as to the Company's beliefs and expectations of the outcome of future events that are forward-looking statements as defined within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties as described in the filings made from time to time by the Company with the Securities and Exchange Commission, including, without limitation, the following: (i) the effect our substantial indebtedness has on our ability to raise additional capital to fund our business, to react to changes in the economy or our business and to fulfill our obligations under our indebtedness, including our ability to meet financial covenants and other conditions of our senior secured credit facility and indenture governing our senior subordinated notes; (ii) our history of losses and accumulated deficit; (iii) our ability to effectively manage our global production capacity, including our ability to recruit, train and retain qualified medical language specialists and maintain high standards of quality service in our operations; (iv) our ability to adapt and integrate new technology into our clinical documentation platforms to improve our production capabilities and expand the breadth of our technology and service offerings; (v) our ability to maintain our competitive position against current and future competitors, including our ability to gain new business with acceptable operating margins and ongoing price pressures related to our technology and services and the healthcare markets in general; (vi) the reluctance of potential customers to outsource or change providers of their clinical documentation technology and services and its impact on our ability to attract new customers and increase revenues; (vii) financial and operational risks inherent in our global operations, including foreign currency exchange rate fluctuations and transfer pricing laws between the United States and India; (viii) our ability to attract, hire or retain technical and managerial personnel necessary to develop and implement technology and services to our customers; (ix) the effect on our business if we incur additional debt and assume contingent liabilities and expenses in connection with future acquisitions or if we cannot effectively integrate newly acquired operations; and (x) our ability to adequately protect our intellectual property rights, including our proprietary technology and the intellectual property we license from third parties.

The Company takes no responsibility for updating the information contained in this press release following the date hereof to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events or for any changes or modifications made to this press release.

SPHERIS INC.

Condensed Consolidated Statements of Operations

(Unaudited and Amounts in Thousands)

Three Months ended Nine Months Ended

September 30, September 30,

2008 2007 2008 2007

Net revenues $44,749 $48,943 $141,074 $151,795

Operating expenses:

Direct costs of revenues

(exclusive of depreciation

and amortization below) 31,673 35,144 102,775 108,804

Marketing and selling

expenses 400 1,186 2,276 3,755

General and administrative

expenses 5,640 5,028 17,337 14,939

Depreciation and

amortization 5,862 6,039 17,720 18,172

Total operating costs 43,575 47,397 140,108 145,670

Operating income 1,174 1,546 966 6,125

Interest expense, net of

income 4,681 5,280 14,379 16,133

Loss on debt refinancing - 1,828 - 1,828

Other (income) expense 820 (149) 1,438 330

Net loss before income

taxes (4,327) (5,413) (14,851) (12,166)

Benefit from income taxes (1,736) (1,872) (5,569) (4,638)

Net loss $(2,591) $(3,541) $(9,282) $(7,528)

SPHERIS INC.

Condensed Consolidated Balance Sheets

(Amounts in Thousands, Except Share Amounts)

(Unaudited)

September 30, December 31,

2008 2007

Assets

Current assets

Unrestricted cash and cash equivalents $9,902 $7,195

Restricted cash 309 309

Accounts receivable, net of allowance of

$1,387 and $1,569, respectively 30,514 33,595

Deferred taxes 4,635 3,386

Prepaid expenses and other current assets 5,365 4,460

Total current assets 50,725 48,945

Property and equipment, net 12,830 12,747

Internal-use software, net 1,712 1,932

Customer contracts, net 1,987 13,968

Goodwill 218,841 218,841

Deferred taxes 4,557 -

Other noncurrent assets 5,808 3,689

Total assets $296,460 $300,122

Liabilities and stockholders' equity

Current liabilities

Accounts payable $2,911 $4,237

Accrued wages and benefits 12,540 18,130

Current portion of long-term debt and

lease obligations 387 35

Other current liabilities 8,510 4,324

Total current liabilities 24,348 26,726

Long-term debt and lease obligations,

net of current portion 199,907 191,761

Deferred tax liabilities - 92

Other long-term liabilities 4,742 4,857

Total liabilities 228,997 223,436

Commitments and contingencies

Common stock, $0.01 par value, 100

shares authorized, 10 shares issued and

outstanding - -

Other comprehensive income 181 564

Contributed capital 111,600 111,158

Accumulated deficit (44,318) (35,036)

Total stockholders' equity 67,463 76,686

Total liabilities and stockholders'

equity $296,460 $300,122

SPHERIS INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited and Amounts in Thousands)

Nine Months Ended

September 30,

2008 2007

Cash flows from operating activities:

Net loss $(9,282) $(7,528)

Adjustments to reconcile net loss to net cash

provided by operating activities:

Depreciation and amortization 17,720 18,172

Amortization of acquired technology 162 486

Deferred taxes (5,898) (5,198)

Change in fair value of derivative financial

instruments 1,311 (10)

Amortization of debt discounts and

issuance costs 630 602

Loss on debt refinancing - 1,828

Other non-cash items 471 305

Changes in operating assets and liabilities, net

of acquisitions:

Accounts receivable 3,081 (345)

Prepaid expenses and other current assets (991) (1,031)

Accounts payable (1,326) (872)

Accrued wages and benefits (5,590) (993)

Other current liabilities 3,090 4,369

Other noncurrent assets and liabilities (2,385) (4)

Net cash provided by operating activities 993 9,781

Cash flows from investing activities:

Purchases of property and equipment (4,241) (3,086)

Purchase and development of internal-use

software (748) (558)

Purchase of Vianeta, net of cash acquired - (1,547)

Net cash used in investing activities (4,989) (5,191)

Cash flows from financing activities:

Proceeds from debt 7,288 71,320

Payments on debt and lease obligations (202) (76,051)

Debt issuance costs - (583)

Net cash provided by (used in) financing

activities 7,086 (5,314)

Effect of exchange rate change on cash and cash

equivalents (383) 836

Net increase in unrestricted cash and cash

equivalents 2,707 112

Unrestricted cash and cash equivalents, at

beginning of period 7,195 6,323

Unrestricted cash and cash equivalents, at end

of period $9,902 $6,435

Supplemental Schedule of Non-cash Investing and

Financing Activities:

Purchases of property and equipment and

internal-use software through lease obligations $1,019 $-

SPHERIS INC.

Supplemental Financial Information

(Unaudited and Amounts in Thousands)

Three Months Ended Nine months Ended

September 30, September 30,

2008 2007 2008 2007

Net loss $(2,591) $(3,541) $(9,282) $(7,528)

Depreciation and

amortization 5,862 6,039 17,720 18,172

Interest expense, net of

income 4,681 5,280 14,379 16,133

Loss on debt refinancing - 1,828 - 1,828

Other (income) expense 820 (149) 1,438 330

Benefit from income

taxes (1,736) (1,872) (5,569) (4,638)

Adjusted EBITDA $7,036 $7,585 $18,686 $24,297

Note to Supplemental Financial Information

The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, and other expense or income (including mark-to-market adjustments related to the Company's derivative financial instruments). Adjusted EBITDA is a financial measure not computed in accordance with United States generally accepted accounting principles, or GAAP. The Company believes that this non-GAAP measure, when presented in conjunction with the comparable GAAP measure, is useful to both management and investors in analyzing the Company's ongoing business and operating performance. The Company believes that providing the non-GAAP information to investors, in addition to the GAAP presentation, allows investors to view the Company's financial results in the way management and the Company's senior lenders view the Company's operating results. Management believes Adjusted EBITDA is useful as a supplemental measure of the performance of the Company's operations because it isolates the Company's operating performance from the accounting impact of the Company's financing strategies, tax provisions, and depreciation and amortization. Additionally, since Adjusted EBITDA is a significant component of certain financial covenants under the Company's senior secured credit facility agreement, management believes Adjusted EBITDA is useful for investors to better assess the Company's compliance with these financial covenants. Management believes Adjusted EBITDA should be considered in addition to, but not as a substitute for, items prepared in accordance with GAAP that are presented in this press release, as the items excluded in the presentation of Adjusted EBITDA are significant components in understanding and assessing financial performance. A reconciliation of Adjusted EBITDA to the nearest comparable GAAP financial measure is provided above. Adjusted EBITDA, as presented, may not be comparable to similarly titled measures of other companies.


'/>"/>
SOURCE Spheris
Copyright©2008 PR Newswire.
All rights reserved


Related medicine news :

1. Spheris Reports Fourth Quarter and Year-End 2007 Results
2. Spheris Sets Fourth Quarter 2007 Earnings Release and Conference Call Dates
3. Spheris Elects New Board Member
4. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
5. Symmetry Medical Reports Third Quarter 2008 Financial Results
6. EntreMed Reports Clinical Program Progress and Company Update
7. NBTY Reports Fourth Quarter and Fiscal Year Results
8. IPC The Hospitalist Company Reports Record Third Quarter 2008 Results
9. Consumer Reports Survey: Nearly Half of Adults Wont Get Flu Vaccine, Citing Poor Excuses Like I Dont Get Sick
10. Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data
11. MIB Life Index Reports North American Life Insurance Activity Off 1.8% in October
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... With FCPX Overlay Embers from Pixel Film Studios users ... Pro X. Each user can select from up to 40 effect overlays. With FCPX ... offset, hue, saturation, value, contrast, glow, and more all within a click of a ...
(Date:2/13/2016)... ... 13, 2016 , ... In the early or “honeymoon” stage of a relationship, ... out of their way to be romantic, and may exaggerate a strength or two ... online dating profile. , A recent study from Queendom.com , however, suggests ...
(Date:2/12/2016)... WA, and Washington, DC (PRWEB) , ... ... ... PATH and the Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH ... for low-resource settings. The partnership will recruit top students from U.S. universities ...
(Date:2/12/2016)... , ... February 12, 2016 , ... As a former ... schedule, a demanding job, and no time to decompress, Rabinowitz found herself drawn to ... to meditation for its impact on her life, implementing a 20-minute-per-day meditation practice with ...
(Date:2/12/2016)... ... February 12, 2016 , ... Every winter, someone is killed, injured or ... West Penn Burn Center, part of the Allegheny Health Network, has partnered with ... the “Space Heaters Need Space” campaign. , “Space Heaters Need Space” aims ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Feb. 11, 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today ... December 31, 2015. The Company also filed its Quarterly Report ... 2016 with the Securities and Exchange Commission today. ... 2015 --> --> Net ... $2.6 million, or 95%, to $5.4 million from $2.8 million ...
(Date:2/11/2016)... , Feb. 11, 2016  Kindred Biosciences, Inc. ... saving and improving the lives of pets, today announced ... of the New Animal Drug Application (NADA) for Zimeta™ ... field study (KB0120) of Zimeta for the control of ... Company. --> --> ...
(Date:2/11/2016)... DUNKIRK, N.Y. , Feb. 11, 2016  Governor ... Athenex that will create 1,400 jobs throughout ... by a partnership with the SUNY Polytechnic Institute, includes ... the Conventus Building in Buffalo , ... square foot manufacturing facility in Dunkirk ...
Breaking Medicine Technology: